Tugba GURSOY, Yesim COSKUN, Kalender KAYAS, Secil ERCİN

Use of silver-impregnated umbilical venous catheters for prevention of catheter associated bloodstream infection in neonates

Aim: Neonates hospitalized in neonatal intensive care units (NICU)s often require a venous access. Umbilical venous catheter (UVC) is the commonly used one. UVCs are known to cause life-threatening complications such as catheter-associated bloodstream infections (CABSI). To the best of our knowledge, our unit is the first and only NICU in Turkey that used silver-impregnated UVCs. This study aims to evaluate the impact of silver-impregnated UVC insertion on the incidence of CABSI. Materials and Methods: A total of 108 patients were included in this retrospective study. After the application of exclusion criteria, the control group was composed of neonates (n=58) who had polyurethane (PU) UVCs inserted and the study group consisted of infants (n=41) who had silver-impregnated UVCs inserted. Demographic and clinical data of the mothers and neonates including duration of UVC insertion and sepsis incidence were collected and compared statistically. Results: There was no statistically significant difference between the groups except for intubation period and mortality. One neonate in each group had CABSI (p=1). Four neonates, two in each group, were diagnosed with clinical sepsis. Total CABSI incidence in our whole population was 2% and 3.3 per 1000 catheter days. Conclusion: Strict precautions should be taken to prevent infection in every unit. In NICUs with low incidence of sepsis, silverimpregnated UVCs may have no further effect in the reduction of CABSI.

PDF

___

1. Lindquist S, Hentz E, Tessin I, et al. Very low birthweight infants face an increased risk of bloodstream infections following the removal of umbilical catheters. Acta Paediatr 2016;105:391-6.
2. Arnts IJ, Bullens LM, Groenewoud JM, et al. Comparison of complication rates between umbilical and peripherally inserted central venous catheters in newborns. J Obstet Gynecol Neonatal Nurs 2014;43:205-15.
3. Shahid S, Dutta S, Symington A, et al. Standardizing umbilical catheter usage in preterm infants. Pediatrics 2014;133:1742-52.
4. Dongara AR, Patel DV, Nimbalkar SM, et al. Umbilical Venous Catheter Versus Peripherally Inserted Central Catheter in Neonates: A Randomized Controlled Trial. J Trop Pediatr 2017;63:374-9.
5. Shalabi M, Adel M, Yoon E, et al; Canadian Neonatal Network. Risk of Infection Using Peripherally Inserted Central and Umbilical Catheters in Preterm Neonates. Pediatrics 2015;136:1073-9.
6. Pereira GR, Lim BK, Ing C, et al. Umbilical vs peripheral vein catheterization for parenteral nutrition in sick premature neonates. Yonsei Med J 1992;33:224-31.
7. Sobczak A, Klepacka J, Amrom D, et al. Umbilical catheters as vectors for generalized bacterial infection in premature infants regardless of antibiotic use. J Med Microbiol 2019;68:1306-13.
8. Goh SSM, Kan SY, Bharadwaj S, et al. A review of umbilical venous catheter-related complications at a tertiary neonatal unit in Singapore. Singapore Med J 2019.
9. Yadav S, Dutta AK, Sarin SK. Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr 1993;17:392- 6.
10. Oelberg DG, Baker A, Quast D, et al. Impact of umbilical catheterization on morbidity and mortality in extremely premature newborns. J Neonatal Perinatal Med 2014;7:13-9.
11. Butler-O'Hara M, Buzzard CJ, Reubens L, et al. A randomized trial comparing long-term and shortterm use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics 2006;118:25-35.
12. Chien LY, Macnab Y, Aziz K, et al; Canadian Neonatal Network. Variations in central venous catheter-related infection risks among Canadian neonatal intensive care units. Pediatr Infect Dis J 2002;21:505-11.
13. Schulman J, Stricof R, Stevens TP, et al.; Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011;127:436-44.
14. Yumani DF, van den Dungen FA, van Weissenbruch MM. Incidence and risk factors for catheter-associated bloodstream infections in neonatal intensive care. Acta Paediatr 2013;102:293-8.
15. Bertini G, Elia S, Ceciarini F, et al. Reduction of catheterrelated bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system. Early Hum Dev 2013;89:21-5.
16. Antonelli M, De Pascale G, Ranieri VM, et al. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients. J Hosp Infect 2012;82:101-7.
17. Wang H, Huang T, Jing J, et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect 2010;76:1-11.
18. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidinesilver sulfadiazine- or rifampicin-miconazoleimpregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly. Am J Infect Control 2016;44:50-3.
19. Hockenhull JC, Dwan K, Boland A, et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 2008;12:1-154.
20. Ramritu P, Halton K, Collignon P, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 2008;36:104-17.
21. Guggenbichler JP, Bo¨swald M, Lugauer S, et al. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999;27:16-23.
22. Gilbert RE, Mok Q, Dwan K, et al; CATCH trial investigators. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial. Lancet 2016;387:1732-42.
23. Gallacher DJ, Hart K, Kotecha S. Common respiratory conditions of the newborn. Breathe (Sheff) 2016;12:30- 42.
24. Principi N, Di Pietro GM, Esposito S. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies. J Transl Med 2018;16:36.
25. Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
26. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
27. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheterrelated infections. www. cdc.gov/hicpac/bsi/bsiguidelines-2011.html 2011
28. 28. Balain M, Oddie SJ, McGuire W. Antimicrobialimpregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants. Cochrane Database Syst Rev 2015;(9):CD011078.
29. Hei MY, Zhang XC, Gao XY, et al. Catheter-related infection and pathogens of umbilical venous catheterization in a neonatal intensive care unit in China. Am J Perinatol 2012;29:107-14.
30. Turkish Neonatal Society; Nosocomial Infections Study Group. Nosocomial infections in neonatal units in Turkey: epidemiology, problems, unit policies and opinions of healthcare workers. Turk J Pediatr 2010;52:50-7.
31. L’Hériteau F, Lacavé L, Leboucher B, et al, le comité de pilotage du Réseau NEOCAT. [NEOCAT, surveillance network of catheter-related bloodstream infections in neonates: 2010 data]. Arch Pediatr 2012;19:984-9.
32. Camara D. Minimizing risks associated with peripherally inserted central catheters in the NICU. MCN Am J Matern Child Nurs 2001;26:17-21.
33. Al Raiy B, Fakih MG, Bryan-Nomides N, et al. Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high-risk short-term central venous catheters. Am J Infect Control 2010;38:149-53
34. Konstantinidi A, Sokou R, Panagiotounakou P, et al. Umbilical Venous Catheters and Peripherally Inserted Central Catheters: Are They Equally Safe in VLBW Infants? A Non-Randomized Single Center Study. Medicina (Kaunas) 2019;55:442.
35. Loertzer H, Soukup J, Hamza A, et al. Use of catheterswith the AgION antimicrobial system in kidney transplant recipients to reduce infec-tion risk. Transplant Proc 2006;38:707-10.
36. Corral L, Nolla-Salas M, Iban ̃ez-Nolla J, et al. A prospective,randomized study in critically ill patients using the Oligon Vantexcatheter. J Hosp Infect 2003;55:212-9.
37. Ranucci M, Isgro`G, Giomarelli PP, et al. Impact of oligon centralvenous catheters on catheter colonization and catheter-relatedbloodstream infection. Crit Care Med 2003;31:52-9.
38. Carbon RT, Lugauer S, Geitner U, et al. Reducing catheter-associated infections with silverimpregnated catheters in long-term therapy of children. Infection 1999;27:69-73.
39. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr Opin Infect Dis 2008;21:235-45.
40. Gilbert R, Brown M, Rainford N, et al. PREVAIL trial team. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial. Lancet Child Adolesc Health 2019;3:381-90.